Ilaria Fiordoliva
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.
Journal: Journal of thoracic disease
Published: March 29, 2021
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis.
Journal: Exploration of targeted anti-tumor therapy
Published: January 01, 2021
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 09, 2020
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 27, 2020
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 17, 2020
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer.
Journal: Annals of translational medicine
Published: December 07, 2019
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: September 25, 2019
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 25, 2018
Developments in the management of advanced soft-tissue sarcoma - olaratumab in context.
Journal: OncoTargets and therapy
Published: March 03, 2018
Managing hyponatremia in lung cancer: latest evidence and clinical implications.
Journal: Therapeutic advances in medical oncology
Published: February 06, 2017
Last Updated: 09/26/2026